FDMT STOCK ANALYSIS
Price summary
Last Close
13.00 $
Jul 2, 26
Market Cap
884.8 M $
Q1 2026 (TTM)
52-Week Range
Return and risk cards
Total Return
%+201.6
Volatility
%92.9
Sharpe Ratio
1.21
Sortino Ratio
1.42
Distance to Peak
%-2.3
Maximum Drawdown
-%41.4
Seasonality
Seasonality Chart
Periodic Returns
1M
+40.2%
3M
+37.1%
6M
+73.3%
YTD
+73.3%
1Y
+201.6%
3Y
-27.2%
Returns are computed from split-adjusted closes; dividends are not included.
YTD Return — Stock vs Asset Classes
Year-to-dateStock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
Monthly positivity
Monthly Avg Positive/Negative Close
Frequently Asked Questions
What is the current 4D Molecular Therapeutics Inc (FDMT) stock price?
FDMT last closed at 13.00 $ (Jul 2, 26). Price data is refreshed after every trading day.
What is the market capitalization of 4D Molecular Therapeutics Inc?
4D Molecular Therapeutics Inc (FDMT) has a market capitalization of approximately 884.8 M $ as of the latest reported period.
Who are the main competitors of FDMT?
Key peers of 4D Molecular Therapeutics Inc include Mesoblast Ltd, TELIX Pharmaceuticals Ltd, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S., CSL Ltd. A detailed metric comparison is available on the Peers tab.
Go deeper on FDMT
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.
